For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210412:nBw1fV2m9a&default-theme=true
Form 8.3 - AON PLC Amendment
Ap19
FORM 8.3
Amendment to sales and purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 08 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
452,456 0.20% 1,703,345 0.75%
(2) Derivatives (other than options):
92,511 0.04% 13,691 0.01%
(3) Options and agreements to
purchase/sell: 24,200 0.01% 24,200 0.01%
TOTAL:
569,167 0.25% 1,741,236 0.77%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 235.4800 USD
Purchase 1 236.0500 USD
Purchase 6 235.5191 USD
Purchase 6 235.7050 USD
Purchase 8 235.4218 USD
Purchase 20 235.1900 USD
Purchase 24 235.9833 USD
Purchase 36 235.6061 USD
Purchase 44 235.7125 USD
Purchase 46 235.5504 USD
Purchase 52 235.2449 USD
Purchase 93 235.1873 USD
Purchase 100 235.5300 USD
Purchase 100 235.2100 USD
Purchase 103 235.9361 USD
Purchase 105 235.3100 USD
Purchase 115 235.8359 USD
Purchase 188 235.7389 USD
Purchase 200 235.2900 USD
Purchase 200 235.8400 USD
Purchase 214 235.3532 USD
Purchase 239 235.9248 USD
Purchase 300 235.8133 USD
Purchase 334 235.8888 USD
Purchase 364 237.1287 USD
Purchase 368 235.6521 USD
Purchase 383 235.9213 USD
Purchase 805 236.0305 USD
Purchase 1,240 235.9379 USD
Purchase 1,564 235.6981 USD
Purchase 2,218 237.3200 USD
Purchase 2,700 237.3192 USD
Purchase 3,371 235.9002 USD
Purchase 5,297 235.3504 USD
Purchase 5,643 235.0697 USD
Purchase 6,624 235.8805 USD
Purchase 7,757 235.0000 USD
Purchase 8,464 235.8765 USD
Purchase 11,543 235.6208 USD
Purchase 12,409 235.4342 USD
Purchase 13,728 235.8382 USD
Purchase 19,610 235.8426 USD
Purchase 26,987 235.4742 USD
Purchase 31,228 235.5877 USD
Sale 1 235.4400 USD
Sale 1 235.5100 USD
Sale 1 238.1700 USD
Sale 2 236.4200 USD
Sale 2 235.3650 USD
Sale 4 235.2900 USD
Sale 5 235.4100 USD
Sale 5 235.5200 USD
Sale 5 235.3200 USD
Sale 5 235.2650 USD
Sale 6 235.7450 USD
Sale 8 235.9950 USD
Sale 10 235.4650 USD
Sale 10 235.4700 USD
Sale 10 235.4250 USD
Sale 14 235.1675 USD
Sale 15 235.9000 USD
Sale 18 235.9055 USD
Sale 20 235.4200 USD
Sale 25 235.7772 USD
Sale 29 235.1489 USD
Sale 31 235.6041 USD
Sale 32 235.6606 USD
Sale 41 235.2287 USD
Sale 42 235.8259 USD
Sale 44 235.7125 USD
Sale 58 235.6631 USD
Sale 77 235.6522 USD
Sale 93 235.1873 USD
Sale 117 235.4972 USD
Sale 119 235.6663 USD
Sale 200 235.3662 USD
Sale 308 235.5652 USD
Sale 335 237.3147 USD
Sale 349 237.2281 USD
Sale 350 235.3342 USD
Sale 350 235.3400 USD
Sale 375 235.0093 USD
Sale 500 235.8240 USD
Sale 700 235.3107 USD
Sale 707 235.6290 USD
Sale 1,112 235.6687 USD
Sale 1,893 237.3200 USD
Sale 2,182 235.0006 USD
Sale 2,400 235.3591 USD
Sale 5,093 235.0055 USD
Sale 7,860 235.0000 USD
Sale 9,623 235.7971 USD
Sale 10,700 235.9032 USD
Sale 13,267 235.7885 USD
Sale 13,641 235.8366 USD
Sale 40,395 235.5291 USD
Sale 57,665 235.6737 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 12 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -1,200 220.0000 American Jul 16, 2021
Call Options Purchased 1,200 240.0000 American Jul 16, 2021
Call Options Purchased 23,000 220.0000 American Jul 16, 2021
Put Options Purchased -23,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210412005809/en/
(https://www.businesswire.com/news/home/20210412005809/en/)
BARCLAYS PLC
Copyright Business Wire 2021